Xiangyu Medical Files Prospectus: Over Two Decades Focused on Comprehensive Rehabilitation Equipment, No Involvement in Pharmaceuticals, Reagents, or Vaccines

Source: Financial界

This article originates from: Financial AI Telegram

Financial World News on December 15th, news that an investor in the interactive platformSunnyou MedicalQuestion: Hello, may I ask whether your company's medical business mainly focuses on medical devices or related pharmaceutical reagents? Does your company have any vaccine-related business?

The company responded: Sunnyou Medical has been deeply engaged in the entire rehabilitation track for more than 20 years and is a comprehensive manufacturer of intelligent rehabilitation equipment that integrates independent research and development, production, promotion, and sales. The company has always been committed to becoming a leading R&D enterprise providing integrated rehabilitation solutions for "all departments, entire hospitals, whole regions, all populations, all disease types, and the entire life process." It has established a product system covering five major categories of rehabilitation medical devices, 20 series, over 600 varieties, and more than 1,000 models. It has the capability to provide integrated rehabilitation solutions for more than 40 clinical specialties, as well as the ability to build integrated clinical rehabilitation systems for entire hospitals and regional health and wellness integration. The company does not engage in businesses related to pharmaceuticals, reagents, or vaccines.